Hydrogen Bromide → 5-cyclopropyl-4-(2,2-difluoroethoxy)-N-(2-(5-methyl-1,2,4-oxadiazol-3-yl)-1-(methylsulfonyl)propan-2-yl)picolinamide
Reaction equation
[CH:1]1([C:4]2[C:5]([O:13][CH2:14][CH:15]([F:17])[F:16])=[CH:6][C:7]([C:10]([OH:12])=O)=[N:8][CH:9]=2)[CH2:3][CH2:2]1.Cl.[CH3:19][C:20]1[O:24][N:23]=[C:22]([C:25]([NH2:32])([CH3:31])[CH2:26][S:27]([CH3:30])(=[O:29])=[O:28])[N:21]=1.Br>>[CH:1]1([C:4]2[C:5]([O:13][CH2:14][CH:15]([F:17])[F:16])=[CH:6][C:7]([C:10]([NH:32][C:25]([C:22]3[N:21]=[C:20]([CH3:19])[O:24][N:23]=3)([CH3:31])[CH2:26][S:27]([CH3:30])(=[O:29])=[O:28])=[O:12])=[N:8][CH:9]=2)[CH2:2][CH2:3]1Participants
5
Reactant 4
Product 1
Procedure
The title compound was synthesized in analogy to Example 112e, using 5-cyclopropyl-4-(2,2-difluoroethoxy)pyridine-2-carboxylic acid;hydrochloride (example 145d) and 2-(5-methyl-1,2,4-oxadiazol-3-yl)-1-methylsulfonyl-propan-2-amine;hydrobromide (enantiomer B) (example 125b) as starting materials and isolated (25 mg, 31%); MS (ESI, m/z): 445.3 (M+H+).
Workup
- customisolated (25 mg, 31%)
Sources & evidence
- ORD record
- ord-6c1cf3c870274a6bb99b8513efb5ca68
- Source dataset
- uspto-grants-2016_08
- Patent number
- US09409866B2
Reaction notes
Loading…